Australia, Feb. 5 -- CELLTRION Inc., owns the trademark (2605355) for 'IXCLERMA' till Oct. 16, 2035.
Status: protected:
Registered/protected
Class: 5 [Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; immunomodulatory pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases.]
Type of Mark: Word
Date of Acceptance: Nov. 28, 2025
Registration Advertised: Feb. 4
For further details contact JIDAM IP LAW FIRM.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2605355.
Disclaimer: Curated by HT Syndication.
